{"id":"doi:10.1136/jim-2021-001952","kind":"review","title":"Wegovy (Semaglutide): A New Weight Loss Drug for Chronic Weight Management","authors":["Gurdeep Singh","Matthew Krauthamer","Meghan Bjalme-Evans"],"author_count":3,"year":2021,"published":"2021-10-27","venue":"Journal of Investigative Medicine","cited_by":244,"doi":"10.1136/jim-2021-001952","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1136/jim-2021-001952","archive_url":"https://space-kitty.com/papers/doi:10.1136/jim-2021-001952","updated":null,"pmid":"34706925","pmcid":null,"openalex_id":"W3210916260","pdf_url":null,"abstract":null,"abstract_license":null,"license":"cc-by-nc","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}